UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Small-cell lung cancer: what we know, what we need to know and the path forward

Nature reviews. Cancer, 2017-12, Vol.17 (12), p.725-737

2017

Volltextzugriff (PDF)

ASCL1 and NEUROD1 Reveal Heterogeneity in Pulmonary Neuroendocrine Tumors and Regulate Distinct Genetic Programs

Cell reports (Cambridge), 2016-08, Vol.16 (5), p.1259-1272

2016

Volltextzugriff (PDF)

Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers

International journal of cancer, 2006-01, Vol.118 (2), p.257-262

2006

Volltextzugriff (PDF)

Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery

PloS one, 2009-07, Vol.4 (7), p.e6146-e6146

2009

Volltextzugriff (PDF)

ZEB1 drives epithelial-to-mesenchymal transition in lung cancer

The Journal of clinical investigation, 2016-09, Vol.126 (9), p.3219-3235

2016

Volltextzugriff (PDF)

Epidermal growth factor receptor inhibition in lung cancer: the evolving role of individualized therapy

Cancer and metastasis reviews, 2010-03, Vol.29 (1), p.37-48

Gazdar, Adi F.

2010

Volltextzugriff (PDF)

Analysis of TP53 Mutation Status in Human Cancer Cell Lines: A Reassessment

Human mutation, 2014-06, Vol.35 (6), p.756-765

2014

Volltextzugriff (PDF)

Malignant mesothelioma: Facts, Myths, and Hypotheses

Journal of cellular physiology, 2012-01, Vol.227 (1), p.44-58

2012

Volltextzugriff (PDF)

Proportion of Never-Smoker Non-Small Cell Lung Cancer Patients at Three Diverse Institutions

JNCI : Journal of the National Cancer Institute, 2017-01, Vol.109 (7), p.djw295

2017

Volltextzugriff (PDF)

ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers

Proceedings of the National Academy of Sciences - PNAS, 2014-10, Vol.111 (41), p.14788-14793

2014

Volltextzugriff (PDF)

Lung Cancer Cell Lines as Tools for Biomedical Discovery and Research

JNCI : Journal of the National Cancer Institute, 2010-09, Vol.102 (17), p.1310-1321

2010

Volltextzugriff (PDF)

Genomic deregulation of the E2F/Rb pathway leads to activation of the oncogene EZH2 in small cell lung cancer

PloS one, 2013-08, Vol.8 (8), p.e71670-e71670

2013

Volltextzugriff (PDF)

miR-337-3p and its targets STAT3 and RAP1A modulate taxane sensitivity in non-small cell lung cancers

PloS one, 2012-06, Vol.7 (6), p.e39167-e39167

2012

Volltextzugriff (PDF)

Oncogene mutations, copy number gains and mutant allele specific imbalance (MASI) frequently occur together in tumor cells

PloS one, 2009-10, Vol.4 (10), p.e7464-e7464

2009

Volltextzugriff (PDF)

Lung Cancer Signatures in Plasma Based on Proteome Profiling of Mouse Tumor Models

Cancer cell, 2011-09, Vol.20 (3), p.289-299

2011

Volltextzugriff (PDF)

SMARCA4-inactivating mutations increase sensitivity to Aurora kinase A inhibitor VX-680 in non-small cell lung cancers

Nature communications, 2017-01, Vol.8 (1), p.14098-13, Article 14098

2017

Volltextzugriff (PDF)

Role of CPS1 in Cell Growth, Metabolism and Prognosis in LKB1-Inactivated Lung Adenocarcinoma

JNCI : Journal of the National Cancer Institute, 2017-03, Vol.109 (3), p.1

2017

Volltextzugriff (PDF)

Aldehyde Dehydrogenase Activity Selects for Lung Adenocarcinoma Stem Cells Dependent on Notch Signaling

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (23), p.9937-9948

2010

Volltextzugriff (PDF)

Human lung epithelial cells progressed to malignancy through specific oncogenic manipulations

Molecular cancer research, 2013-06, Vol.11 (6), p.638-650

2013

Volltextzugriff (PDF)

PTEN Loss Contributes to Erlotinib Resistance in EGFR-Mutant Lung Cancer by Activation of Akt and EGFR

Cancer research (Chicago, Ill.), 2009-04, Vol.69 (8), p.3256-3261

2009

Volltextzugriff (PDF)

PIK3CA Mutations and Copy Number Gains in Human Lung Cancers

Cancer research (Chicago, Ill.), 2008-09, Vol.68 (17), p.6913-6921

2008

Volltextzugriff (PDF)

The Comparative Pathology of Genetically Engineered Mouse Models for Neuroendocrine Carcinomas of the Lung

Journal of thoracic oncology, 2015-04, Vol.10 (4), p.553-564

2015

Volltextzugriff (PDF)

HER2 kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGFR and resistance to EGFR tyrosine kinase inhibitors

Cancer cell, 2006-07, Vol.10 (1), p.25-38

2006

Volltextzugriff (PDF)

1 – 25 von 729

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(686)
Mit Volltextzugriff
(679)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(506)
Science & Technology
(496)
Life Sciences & Biomedicine
(467)
Oncology
(349)
Biological And Medical Sciences
(291)
Medical Sciences
(267)
Lung Neoplasms - Genetics
(204)
Female
(187)
Tumors
(184)
Lung Neoplasms - Pathology
(149)
Male
(141)
Lung Cancer
(139)
Pneumology
(137)
Tumors Of The Respiratory System And Mediastinum
(135)
Carcinoma, Non-Small-Cell Lung - Genetics
(116)
Middle Aged
(115)
Tumor Cells, Cultured
(110)
Aged
(105)
Animals
(98)
Mutation
(96)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Small-cell lung cancer: what we know, what we need to know and the path forward

ASCL1 and NEUROD1 Reveal Heterogeneity in Pulmonary Neuroendocrine Tumors and Regulate Distinct Genetic Programs

Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers

Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery

ZEB1 drives epithelial-to-mesenchymal transition in lung cancer

Systematic Identification of Molecular Subtype-Selective Vulnerabilities in Non-Small-Cell Lung Cancer

Epidermal growth factor receptor inhibition in lung cancer: the evolving role of individualized therapy

Analysis of TP53 Mutation Status in Human Cancer Cell Lines: A Reassessment

Malignant mesothelioma: Facts, Myths, and Hypotheses

Proportion of Never-Smoker Non-Small Cell Lung Cancer Patients at Three Diverse Institutions

ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers

Lung Cancer Cell Lines as Tools for Biomedical Discovery and Research

Genomic deregulation of the E2F/Rb pathway leads to activation of the oncogene EZH2 in small cell lung cancer

miR-337-3p and its targets STAT3 and RAP1A modulate taxane sensitivity in non-small cell lung cancers

Oncogene mutations, copy number gains and mutant allele specific imbalance (MASI) frequently occur together in tumor cells

Lung Cancer Signatures in Plasma Based on Proteome Profiling of Mouse Tumor Models

SMARCA4-inactivating mutations increase sensitivity to Aurora kinase A inhibitor VX-680 in non-small cell lung cancers

Role of CPS1 in Cell Growth, Metabolism and Prognosis in LKB1-Inactivated Lung Adenocarcinoma

Aldehyde Dehydrogenase Activity Selects for Lung Adenocarcinoma Stem Cells Dependent on Notch Signaling

Human lung epithelial cells progressed to malignancy through specific oncogenic manipulations

PTEN Loss Contributes to Erlotinib Resistance in EGFR-Mutant Lung Cancer by Activation of Akt and EGFR

PIK3CA Mutations and Copy Number Gains in Human Lung Cancers

Genome and transcriptome sequencing of lung cancers reveal diverse mutational and splicing events

The Comparative Pathology of Genetically Engineered Mouse Models for Neuroendocrine Carcinomas of the Lung

HER2 kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGFR and resistance to EGFR tyrosine kinase inhibitors

Suchergebnisse filtern